Neostigmine Methylsulfate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01400 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 35 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | myasthenia gravis with thymus hyperplasia | KG + DL |
| 2 | myasthenia, limb-girdle, autoimmune | KG + DL |
| 3 | autoimmune disease of peripheral nervous system | KG + DL |
| 4 | neonatal myasthenia gravis | KG + DL |
| 5 | disease of receptor activity | KG + DL |
| 6 | hypersplenism (disease) | KG + DL |
| 7 | atypical hemolytic-uremic syndrome with B factor anomaly | KG + DL |
| 8 | bronchitis | KG + DL |
| 9 | fetal akinesia deformation sequence | KG + DL |
| 10 | myasthenia, congenital, refractory to acetylcholinesterase inhibitors | KG + DL |
| 11 | congenital myasthenic syndrome with tubular aggregates | KG + DL |
| 12 | myasthenic syndrome, congenital, 25, presynaptic | KG + DL |
| 13 | myasthenic syndrome, congenital, 24, presynaptic | KG + DL |
| 14 | dermatitis | KG + DL |
| 15 | acrodermatitis chronica atrophicans | KG + DL |
| 16 | pityriasis simplex | KG + DL |
| 17 | secondary interstitial lung disease specific to childhood associated with a connective tissue disease | KG + DL |
| 18 | neonatal dermatomyositis | KG + DL |
| 19 | hydroa vacciniforme, familial | KG + DL |
| 20 | amyopathic dermatomyositis | KG + DL |
| 21 | acne keloid | KG + DL |
| 22 | irritable bowel syndrome | KG + DL |
| 23 | acute liver failure | KG + DL |
| 24 | Chagas cardiomyopathy | KG + DL |
| 25 | post-bacterial disorder | KG + DL |
| 26 | postinfectious vasculitis | KG + DL |
| 27 | post-infectious syndrome | KG + DL |
| 28 | infection-related hemolytic uremic syndrome | KG + DL |
| 29 | infective urethral stricture | KG + DL |
| 30 | obsolete neurogenic bladder (disease) | KG + DL |
| 31 | cauda equina syndrome | KG + DL |
| 32 | pulmonary edema | KG + DL |
| 33 | otitis externa | KG + DL |
| 34 | idiopathic bronchiectasis | KG + DL |
| 35 | congenital myasthenic syndromes with glycosylation defect | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.